- For Patients
- Introduction to the Marshall Protocol
- Length of the MP
- Immunopathology
- Managing immunopathology
- Food and drink
- Light restriction
- Vitamin D metabolite calculator - get feedback on vitamin D results
- Therapeutic probe - best method for determining MP suitability
- Starting the Marshall Protocol
- Resources for patients
- Marshall Protocol summary
- Palliative vs. curative treatments
- Patient interviews on Bacteriality
- Non-MP treatments
- Glossary
- The Protocol
- Marshall Protocol summary
- Publications and presentations
- Science behind immunopathology
- Science behind olmesartan (Benicar)
- Safety of olmesartan
- Resources for physicians
- Vitamin D metabolite calculator - get feedback on vitamin D results
- Therapeutic probe - best method for determining MP suitability
- Physicians' concerns about the MP
- Notice for emergency medical personnel
- The Pathogenesis
- Publications and presentations
- Science behind Marshall Pathogenesis
- Microbes in the human body
- Successive infection and variability in disease
- Autoimmune theory of disease
- Science behind vitamin D
- Metabolism of vitamin D and the VDR
- Th1 Spectrum Disorder - how chronic inflammatory diseases are related
- Transmission of bacteria and onset of chronic disease
- Evolutionary perspective on disease
- Incidence and prevalence of disease
- Evidence that chronic disease is caused by pathogens
- Diseases
- Foundation
- Related Sites
Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revision | Next revisionBoth sides next revision | ||
| home:patients:glossary [08.23.2014] – deemphasized antibiotics paulalbert | home:patients:glossary [08.23.2014] – paulalbert | ||
|---|---|---|---|
| Line 57: | Line 57: | ||
| * **metagenomic microbiota** – The community of bacterial pathogens, including those in an intracellular and biofilm state which cause chronic disease. | * **metagenomic microbiota** – The community of bacterial pathogens, including those in an intracellular and biofilm state which cause chronic disease. | ||
| * **microbiota** – The bacterial community which causes chronic diseases; one which almost certainly includes multiple species and bacterial forms. | * **microbiota** – The bacterial community which causes chronic diseases; one which almost certainly includes multiple species and bacterial forms. | ||
| - | * **minimum inhibitory concentration (MIC)** – The lowest concentration of an antimicrobial that will inhibit the visible growth of a microorganism after overnight incubation. Dosing at well below the MIC improves the MP's effectiveness against slow-growing chronic pathogens and reduces the likelihood of resistance. | ||
| * **minocycline** – Bacteriostatic antibiotic occasionally prescribed for some Marshall Protocol patients as a palliative. | * **minocycline** – Bacteriostatic antibiotic occasionally prescribed for some Marshall Protocol patients as a palliative. | ||
| * **murine model** – A model of disease which uses rats or mice to mimic human conditions. | * **murine model** – A model of disease which uses rats or mice to mimic human conditions. | ||
home/patients/glossary.txt · Last modified: 10.13.2018 by sallieq
© 2015, Autoimmunity Research Foundation. All Rights Reserved.